Max Noble
Menu
CEO Storm Watch · the report5 November 2025

Max Noble

Ambu

Britt Meelby Jensen promised 10–13% growth and a 12–14% margin in 2024/25. Delivered: 13.1% growth, 13.0% margin.

🇩🇰 Denmark · Medical devicesAmbu0.0IntegrityBritt Meelby JensenBritt Meelby JensenCEO, 2022–, AmbuPromisedhow much sales grew in 2024/2510–13%; 12–14%4 November 2024

Last checked · How I check · Follow this CEO

She promised

Sales would grow 10–13%, keeping 12–14 kroner profit on every 100 sold.

Britt Meelby Jensen, CEO, 2022–, on 4 November 2024.

She got

Sales grew 13%, with 13 kroner profit on every 100.

Stamp: Kept.

Why, says the company

Better gross margin and costs growing slower than sales.

How bad

Nothing: the promise was met. The CEO’s Integrity Score went from 0.0 to +10.8.

In the company’s own words

Not needed: target met. Ambu credited an improved gross margin and operating leverage.

The sources

Last checked 30 October 2026: the sources were opened again and the promise and the stamp still stand. How I check.

How the Max Noble Odds moved

Odds: 60% before the first call → verdict on 5 November 2026

The chance of Yes to “Will Ambu grow its sales by about 10% this year, as promised?” The first number is my starting estimate; every call moves it. One point a day is kept from 8 November 2026 to the verdict.

Will Ambu grow its sales by about 10% this year, as promised? Make your call in The Power Game →

Follow this CEO

Get an email the morning Britt Meelby Jensen’s card turns.

One email when the stamp changes or a new promise is checked. Nothing else.

Your choices
Your editions
How often
Breaking Briefs

Next: read today’s Morning Brief →